FDA, DOJ Pursuing Cases of Clinical Trials Fraud

Clinical Trials Advisor
A A
The FDA and Department of Justice are pursuing prosecutions of several international drugmakers, investigators and clinical trials coordinators for conduct and data integrity violations, underscoring the agency’s increasing tendency to treat quality violations as fraud.

To View This Article:

Login

Subscribe To Clinical Trials Advisor